1.Fexofenadine-Induced Urticaria.
Sang Woo LEE ; Ji Yeon BYUN ; You Won CHOI ; Ki Bum MYUNG ; Hae Young CHOI
Annals of Dermatology 2011;23(Suppl 3):S329-S332
Fexofenadine (Allegra(R) 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.
Basophil Degranulation Test
;
Flow Cytometry
;
Hypersensitivity
;
Terfenadine
;
Urticaria
2.Basophil CD63 expression in the blood of the anaphylactic shock rat.
Li-xia JING ; Xiang-jie GUO ; Qian-qian JIN ; Miao-miao HUANG ; Cai-rong GAO
Journal of Forensic Medicine 2012;28(3):172-178
OBJECTIVE:
To explore the value of flow cytometry in anaphylactic shock diagnosis by CD63 expression being detected using flow cytometry to conform the activation of basophils.
METHODS:
Sixteen rats were randomly divided into two groups: control group and anaphylactic shock group. The model of anaphylactic shock rat with ovalbumin injection was established. CD63, CD45 and CD203c antibody combination, flow cytometry was employed to detected blood basophil CD63 expression. Immunofluorescence method was employed to observe the CD63 immunofluorescence staining in the rat lung tissue.
RESULTS:
(1) Pure basophils were obtained by CD45 and CD203c gating. (2) The percentages of basophils CD63 were (17.34 +/- 2.04)% and (1.52 +/- 0.35)% in the experimental and control group, respectively. The differences between two groups were statistically significant (P < 0.01). (3) Compared with the control group, the expression of CD63 in basophils increased in anaphylactic shock lung tissue.
CONCLUSION
The detection of CD63 by flow cytometry could be the supplement of vivo allergic reactions and have good clinical value.
Anaphylaxis/metabolism*
;
Animals
;
Basophil Degranulation Test/methods*
;
Basophils/metabolism*
;
Biomarkers/analysis*
;
Disease Models, Animal
;
Female
;
Flow Cytometry
;
Lung/pathology*
;
Male
;
Ovalbumin/administration & dosage*
;
Phosphoric Diester Hydrolases/immunology*
;
Pyrophosphatases/immunology*
;
Random Allocation
;
Rats
;
Rats, Wistar
;
Tetraspanin 30/metabolism*
3.A Case of Codeine Induced Anaphylaxis via Oral Route.
Hye Soo YOO ; Eun Mi YANG ; Mi Ae KIM ; Sun Hyuk HWANG ; Yoo Seob SHIN ; Young Min YE ; Dong Ho NAHM ; Hae Sim PARK
Allergy, Asthma & Immunology Research 2014;6(1):95-97
Codeine is widely prescribed in clinical settings for the relief of pain and non-productive coughs. Common adverse drug reactions to codeine include constipation, euphoria, nausea, and drowsiness. However, there have been few reports of serious adverse reactions after codeine ingestion in adults. Here, we present a case of severe anaphylaxis after oral ingestion of a therapeutic dose of codeine. A 30-year-old Korean woman complained of the sudden onset of dyspnea, urticaria, chest tightness, and dizziness 10 minutes after taking a 10-mg dose of codeine to treat a chronic cough following a viral infection. She had previously experienced episodes of asthma exacerbation following upper respiratory infections, and had non-atopic rhinitis and a food allergy to seafood. A skin prick test showed a positive response to 1-10 mg/mL of codeine extract, with a mean wheal size of 3.5 mm, while negative results were obtained in 3 healthy adult controls. A basophil histamine release test showed a notable dose-dependent increase in histamine following serial incubations with codeine phosphate, while there were minimal changes in the healthy controls. Following a CYP2D6 genotype analysis, the patient was found to have the CYP2D6*1/*10 allele, indicating she was an intermediate metabolizer. An open label oral challenge test was positive. To the best of our knowledge, this is the first report of a patient presenting with severe anaphylaxis after the ingestion of a therapeutic dose of codeine, which may be mediated by the direct release of histamine by basophils following exposure to codeine.
Adult
;
Alleles
;
Anaphylaxis*
;
Asthma
;
Basophil Degranulation Test
;
Basophils
;
Codeine*
;
Constipation
;
Cough
;
Cytochrome P-450 CYP2D6
;
Dizziness
;
Drug-Related Side Effects and Adverse Reactions
;
Dyspnea
;
Eating
;
Euphoria
;
Female
;
Food Hypersensitivity
;
Genotype
;
Histamine
;
Histamine Release
;
Humans
;
Nausea
;
Respiratory Tract Infections
;
Rhinitis
;
Seafood
;
Skin
;
Sleep Stages
;
Thorax
;
Urticaria